Cannabis drug succeeds in epilepsy, doubling value of GW Pharma

LONDON (Reuters) - An experimental cannabis-based drug has successfully treated children with a rare form of severe epilepsy in a keenly anticipated clinical trial, more than doubling the value of its maker GW Pharmaceuticals.